MedTrace Logo

Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction

NCT02864446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-08-12

No results posted yet for this study

Summary

Urinary intestinal fatty acid binding protein (i-FABP), a marker of intestinal mucosal cell damage, has recently been proposed as a clinically useful measure in the early detection of necrotizing enterocolitis (NEC). However, there are no data on urinary i-FABP in meconium obstruction of prematurity (MOP). This study aimed to evaluate urinary i-FABP in MOP patient as a marker for early detection.

Conditions

  • Meconium Obstruction of Prematurity

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Max Age
36 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02864446 on ClinicalTrials.gov